Anti-Rheumatics Market Report by Type (Prescription-based Drugs, Over-the-Counter Drugs), Drug Class (Disease Modifying Anti-Rheumatics Drugs (DMARD's), Nonsteroidal Anti-Inflammatory Drugs (NSAID's), Corticosteroids, Uric Acid Drugs, and Others), Route of Drug Administration (Oral, Parenteral, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-Commerce), and Region 2025-2033

Anti-Rheumatics Market Report by Type (Prescription-based Drugs, Over-the-Counter Drugs), Drug Class (Disease Modifying Anti-Rheumatics Drugs (DMARD's), Nonsteroidal Anti-Inflammatory Drugs (NSAID's), Corticosteroids, Uric Acid Drugs, and Others), Route of Drug Administration (Oral, Parenteral, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-Commerce), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A4148

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Anti-Rheumatics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Type
    6.1    Prescription-based Drugs
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Over-the-Counter Drugs
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by Drug Class
    7.1    Disease Modifying Anti-Rheumatics Drugs (DMARD's)
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Nonsteroidal Anti-Inflammatory Drugs (NSAID's)
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Corticosteroids
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Uric Acid Drugs
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8   Market Breakup by Route of Drug Administration
    8.1    Oral
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Parenteral
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9   Market Breakup by Distribution Channel
    9.1    Hospital Pharmacies
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Retail Pharmacies
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    E-Commerce
        9.3.1 Market Trends
        9.3.2 Market Forecast
10  Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Analysis
15  Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    AbbVie Inc.
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Amgen Inc.
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials
           15.3.2.4 SWOT Analysis
        15.3.3    AstraZeneca plc
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    Biogen Inc.
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 Financials
           15.3.4.4 SWOT Analysis
        15.3.5    Bristol-Myers Squibb Company
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
           15.3.5.4 SWOT Analysis
        15.3.6    Celltrion Inc.
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 Financials
           15.3.6.4 SWOT Analysis
        15.3.7    Eli Lilly and Company
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials
           15.3.7.4 SWOT Analysis
        15.3.8    F. Hoffmann-La Roche AG
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
        15.3.9    Johnson & Johnsons
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    Pfizer Inc.
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis
        15.3.11    Sanofi SA
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
           15.3.11.3 Financials
           15.3.11.4 SWOT Analysis

List of Figures

​Figure 1: Global: Anti-Rheumatics Market: Major Drivers and Challenges
Figure 2: Global: Anti-Rheumatics Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Anti-Rheumatics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Anti-Rheumatics Market: Breakup by Type (in %), 2024
Figure 5: Global: Anti-Rheumatics Market: Breakup by Drug Class (in %), 2024
Figure 6: Global: Anti-Rheumatics Market: Breakup by Route of Drug Administration (in %), 2024
Figure 7: Global: Anti-Rheumatics Market: Breakup by Distribution Channel (in %), 2024
Figure 8: Global: Anti-Rheumatics Market: Breakup by Region (in %), 2024
Figure 9: Global: Anti-Rheumatics (Prescription-based Drugs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Anti-Rheumatics (Prescription-based Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Anti-Rheumatics (Over-the-Counter Drugs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Anti-Rheumatics (Over-the-Counter Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Anti-Rheumatics (Disease Modifying Anti-Rheumatics Drugs (DMARD's)) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Anti-Rheumatics (Disease Modifying Anti-Rheumatics Drugs (DMARD's)) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Anti-Rheumatics (Nonsteroidal Anti-Inflammatory Drugs (NSAID's)) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Anti-Rheumatics (Nonsteroidal Anti-Inflammatory Drugs (NSAID's)) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Anti-Rheumatics (Corticosteroids) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Anti-Rheumatics (Corticosteroids) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Anti-Rheumatics (Uric Acid Drugs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Anti-Rheumatics (Uric Acid Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Anti-Rheumatics (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Anti-Rheumatics (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Anti-Rheumatics (Oral) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Anti-Rheumatics (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Anti-Rheumatics (Parenteral) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Anti-Rheumatics (Parenteral) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Anti-Rheumatics (Other Routes of Drug Administration) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Anti-Rheumatics (Other Routes of Drug Administration) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Anti-Rheumatics (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Anti-Rheumatics (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Global: Anti-Rheumatics (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Global: Anti-Rheumatics (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Global: Anti-Rheumatics (E-Commerce) Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Global: Anti-Rheumatics (E-Commerce) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: North America: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: North America: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: United States: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: United States: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Canada: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Canada: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Asia-Pacific: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Asia-Pacific: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: China: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: China: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: Japan: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: Japan: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: India: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: India: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: South Korea: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: South Korea: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Australia: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Australia: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: Indonesia: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: Indonesia: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Others: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Others: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Europe: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Europe: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Germany: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Germany: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: France: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: France: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: United Kingdom: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: United Kingdom: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Italy: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Italy: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Spain: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Spain: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Russia: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Russia: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Others: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Others: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Latin America: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Latin America: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Brazil: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Brazil: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Mexico: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Mexico: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Others: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 80: Others: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Middle East and Africa: Anti-Rheumatics Market: Sales Value (in Million USD), 2019 & 2024
Figure 82: Middle East and Africa: Anti-Rheumatics Market: Breakup by Country (in %), 2024
Figure 83: Middle East and Africa: Anti-Rheumatics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 84: Global: Anti-Rheumatics Industry: SWOT Analysis
Figure 85: Global: Anti-Rheumatics Industry: Value Chain Analysis
Figure 86: Global: Anti-Rheumatics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Anti-Rheumatics Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Anti-Rheumatics Market Forecast: Breakup by Type (in Million USD), 2025-2033
Table 3: Global: Anti-Rheumatics Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
Table 4: Global: Anti-Rheumatics Market Forecast: Breakup by Route of Drug Administration (in Million USD), 2025-2033
Table 5: Global: Anti-Rheumatics Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
Table 6: Global: Anti-Rheumatics Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Anti-Rheumatics Market: Competitive Structure
Table 8: Global: Anti-Rheumatics Market: Key Players

Anti-Rheumatics Market Report by Type (Prescription-based Drugs, Over-the-Counter Drugs), Drug Class (Disease Modifying Anti-Rheumatics Drugs (DMARD's), Nonsteroidal Anti-Inflammatory Drugs (NSAID's), Corticosteroids, Uric Acid Drugs, and Others), Route of Drug Administration (Oral, Parenteral, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-Commerce), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials